| Literature DB >> 26628937 |
Yong-Gan Zhang1, Xue-Li Guo1, Yan Song1, Chao-Feng Miao1, Chuang Zhang1, Ning-Heng Chen1.
Abstract
Surgical site infection (SSI) is an important component of infections acquired from hospital. The most significant feature of vascular surgery different from other surgeries is frequent application of artificial grafts. Once SSI occurs after vascular operations with grafts, it might results in a serious disaster. Staphylococcus aureus and coagulase-negative Staphylococcus are the most common pathogenic bacteria for SSI after vascular surgery. Although SSI in vascular surgery often lacks of typical clinical characters, some clinical symptoms, laboratory data and certain imaging procedures may help to diagnose. In most cases of SSI after vascular procedures, the artificial grafts must be removed and sensitive antibiotics should be administered. However, for different cases, personalized management plan should be made depending on the severity and location of SSI.Entities:
Keywords: Antibiotics; diagnosis; infection; treatment; vascular surgery
Year: 2015 PMID: 26628937 PMCID: PMC4645830 DOI: 10.2174/1874120701509010250
Source DB: PubMed Journal: Open Biomed Eng J ISSN: 1874-1207
Binary logistic regression analysisa of factors associ-ated with surgical wound infection after lower limb vascular surgery.
| Risk factor | OR | 95% CI | p |
|---|---|---|---|
| CFU/mL >155,000 on the second postoperative day | 5.97 | 1.67–21.42 | .006 |
| Diabetes | 4.77 | 1.46–15.55 | .010 |
| Elective redo surgery | 0.16 | 0.03–0.88 | .035 |
| Infra-inguinal surgery | 4.11 | 0.95–17.84 | .059 |
| Male gender | 4.41 | 0.90–21.71 | .068 |
Note. OR = odds ratio; CI = confidence interval; CFU = colony-forming unit.
a Regression model with CFU/mL >155,000 on the second postoperative day, diabetes, elective redo surgery, infra-inguinal surgery, and sex as covariates.
Type and number of bacterial and fungal isolates recovered from 42 vascular surgical sites.
| Type | No. |
|---|---|
| Gram-positive | |
| Staphylococcus aureus | |
| Methicillin-resistant | 10 |
| Methicillin-sensitive | 5 |
| S. epidermidis | 6 |
| Enterococcus | 7 |
| Streptococcus spp | 2 |
| Methicillin-resistant S. epidermidis | 1 |
| Vancomycin-resistant Enterococcus | 1 |
| Bacteroides spp | 7 |
| Total | 39 |
| Gram-negative | |
| Escherichia coli | 7 |
| Pseudomonas | 3 |
| Haemophilus | 1 |
| Proteus | 1 |
| Citrobacter | 1 |
| Klebsiella | 1 |
| Enterobacter | 2 |
| Propionibacterium acnes | 2 |
| Total | 18 |
| Candida | 2 |
| No growth | 2 |
Predictors of cure at one year in 51 patients with aortic prosthetic vascular graft infections.
| Variable | Univariate Analysis | Multivariate Analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p-Value | HR | 95% CI | p-Value | |
| Age | 0.33 | 0.15–0.74 | 0.007 | 0.45 | 0.19–1.11 | 0.083 |
| Female gender | 0.96 | 0.15–6.35 | 0.970 | — | — | — |
| Location of the Graft | ||||||
| Thoracic | 1 | — | — | — | — | — |
| Abdominal, with noiliac-femoral graft involvement | 0.14 | 0.02–1.06 | 0.057 | — | — | — |
| Abdominal withiliac-femoral graft involvement | 0.07 | 0.02–0.32 | 0.001 | 0.24 | 0.05–1.16 | 0.076 |
| Intubation >24 hours | 0.44 | 0.10–1.91 | 0.276 | — | — | — |
| Early surgical graft revision <24 hours after implantation | 1.30 | 0.42–4.03 | 0.645 | — | — | — |
| Polymicrobial infection | 0.72 | 0.23–2.24 | 0.573 | 1.93 | 0.41–9.13 | 0.405 |
| Type of Surgical Treatment | ||||||
| Graft retention and debridement | 0.46 | 0.14–1.50 | 0.196 | — | — | — |
| Graft replacement | 0.87 | 0.23–3.26 | 0.842 | 0.89 | 0.15–5.31 | 0.899 |
| Local Surgical Therapy Associated with Graft Revisions/Replacements | ||||||
| Vacuum-assisted closure | 0.54 | 0.16–1.88 | 0.335 | — | — | — |
| Plastic surgery | 0.96 | 0.15–6.35 | 0.970 | — | — | — |
| Antimicrobial Therapy | ||||||
| Antimicrobial regimen that included rifampicin | 7.85 | 1.90–32.4 | 0.004 | 6.88 | 1.33–35.4 | 0.021 |